Neutral and ionic platinum compounds containing a cyclometalated chiral primary amine: Synthesis, antitumor activity, DNA interaction and topoisomerase I - cathepsin B inhibition

dc.contributor.authorAlbert Mach, Joan
dc.contributor.authorBosque Pueyo, Ramón
dc.contributor.authorCrespo, M.
dc.contributor.authorGranell Sanvicente, Jaime Ramón
dc.contributor.authorLópez Martínez, Ma. Concepción
dc.contributor.authorMartín, Raquel
dc.contributor.authorGonzález, A.
dc.contributor.authorJayaraman, A.
dc.contributor.authorQuirante Serrano, Josefina
dc.contributor.authorCalvis, Carme
dc.contributor.authorBadía Palacín, Josefa
dc.contributor.authorBaldomà Llavinés, Laura
dc.contributor.authorFont Bardia, Ma. Mercedes
dc.contributor.authorCascante i Serratosa, Marta
dc.contributor.authorMesseguer i Peypoch, Ramon
dc.date.accessioned2020-06-08T18:20:00Z
dc.date.available2020-06-08T18:20:00Z
dc.date.issued2015
dc.date.updated2020-06-08T18:20:00Z
dc.description.abstractThe synthesis and preliminary biological evaluation of neutral and cationic platinum derivatives of chiral 1-(1-naphthyl)ethylamine are reported, namely cycloplatinated neutral complexes [PtCl{(R or S)-NH(2)CH(CH(3))C(10)H(6)}(L)] [L = SOMe(2) ( 1-R or 1-S ), L = PPh(3) (2-R or 2-S), L = P(4-FC(6)H(4))(3) (3-R), L = P(CH(2))(3)N(3)(CH(2))(3) (4-R)], cycloplatinated cationic complexes [Pt{(R)-NH(2)CH(CH(3))C(10)H(6)}{L}]Cl [L = Ph(2)PCH(2)CH(2)PPh(2) (5-R), L = (C(6)F(5))(2)PCH(2)CH(2)P(C(6)F(5))(2) (6-R)] and the Pt(ii) coordination compound trans-[PtCl(2){(R)-NH(2)CH(CH(3))C(10)H(6)}(2)] (7-R). The X-ray molecular structure of 7-R is reported. The cytotoxic activity against a panel of human adenocarcinoma cell lines (A-549 lung, MDA-MB-231 and MCF-7 breast, and HCT-116 colon), cell cycle arrest and apoptosis, DNA interaction, topoisomerase I and cathepsin B inhibition, and Pt cell uptake of the studied compounds are presented. Remarkable cytotoxicity was observed for most of the synthesized Pt(ii) compounds regardless of (i) the absolute configuration R or S, and (ii) the coordinated/cyclometallated (neutral or cationic) nature of the complexes. The most potent compound 2-R (IC(50) = 270 nM) showed a 148-fold increase in potency with regard to cisplatin in HCT-116 colon cancer cells. Preliminary biological results point out to different biomolecular targets for the investigated compounds. Neutral cyclometallated complexes 1-R and 2-R, modify the DNA migration as cisplatin, cationic platinacycle 5-R was able to inhibit topoisomerase I-promoted DNA supercoiling, and Pt(ii) coordination compound 7-R turned out to be the most potent inhibitor of cathepsin B. Induction of G-1 phase ( 2-R and 5-R ), and S and G-2 phases (6-R) arrests are related to the antiproliferative activity of some representative compounds upon A-549 cells. Induction of apoptosis is also observed for 2-R and 6-R.
dc.format.extent35 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec653582
dc.identifier.issn1477-9226
dc.identifier.urihttps://hdl.handle.net/2445/164842
dc.language.isoeng
dc.publisherRoyal Society of Chemistry
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1039/c5dt01713k
dc.relation.ispartofDalton Transactions, 2015, vol. 44, num. 30, p. 13602-13614
dc.relation.urihttps://doi.org/10.1039/c5dt01713k
dc.rights(c) Albert Mach, Joan et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Mineralogia, Petrologia i Geologia Aplicada)
dc.subject.classificationPlatí
dc.subject.classificationCàncer
dc.subject.otherPlatinum
dc.subject.otherCancer
dc.titleNeutral and ionic platinum compounds containing a cyclometalated chiral primary amine: Synthesis, antitumor activity, DNA interaction and topoisomerase I - cathepsin B inhibition
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
653582.pdf
Mida:
1.37 MB
Format:
Adobe Portable Document Format